Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 10/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 7/20 | 0.68 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2913106 | 0.97 | KCNH2 (0.67) | CSF1RKCNH2SCN5ALMNAMAPT | |
| SCHEMBL2913425 | 0.95 | CSF1R (0.64) | CSF1RKCNH2SCN5AMAPT | |
| SCHEMBL2904389 | 0.94 | KCNH2 (0.69) | CSF1RKCNH2SCN5ALMNAMAPT | |
| SCHEMBL2911034 | 0.92 | CSF1R (0.61) | CSF1RKCNH2SCN5A | |
| SCHEMBL2910312 | 0.90 | KCNH2 (0.60) | CSF1RKCNH2SCN5ALMNAMAPT | |
| SCHEMBL2911029 | 0.89 | CSF1R (0.84) | CSF1RKCNH2SCN5A | |
| SCHEMBL2911267 | 0.89 | CSF1R (0.72) | CSF1RKCNH2SCN5A | |
| SCHEMBL2912345 | 0.88 | CSF1R (0.71) | CSF1RKCNH2SCN5ALMNAMAPT | |
| SCHEMBL2914184 | 0.87 | CSF1R (0.70) | CSF1RKCNH2SCN5ALMNAMAPT | |
| SCHEMBL2913777 | 0.87 | KCNH2 (0.58) | CSF1RKCNH2SCN5AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2010496-B1 | 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2010-08-25 | — | — | EP | disclosed |